Poxel Reports Revenue for the Full Year 2024 and Provides an Update o…Following the non-adoption of key financial delegations at the Combined... |
Poxel publie son chiffre d’affaires pour l’exercice 2024 et fait le p…Suite à la non-adoption des principales délégations financières lors de... |
Poxel : nombre d’actions et de droits de vote composant le capital so…Regulatory News: Poxel (Paris:POXEL) : conformément aux dispositions de... |
Poxel annonce les résultats de son Assemblée Générale Mixte du 11 fév…Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), société... |
Poxel Announces Results of its Combined General Meeting Held on Febru…Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical... |
Poxel publie les ventes brutes de TWYMEEG® au Japon pour le quatrième…Les ventes de TWYMEEG® continuent de progresser au Japon, en hausse de 17... |
Poxel’s partner Sumitomo Pharma reports TWYMEEG® gross sales in Japan…TWYMEEG® sales continued to increase in Japan for the last quarter 2024... |
Poxel annonce son agenda financier pour l’exercice 2025Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), société... |
Poxel Announces its Financial Calendar for 2025Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), a clinical... |
Poxel : Assemblée générale ordinaire et extraordinaire du 11 février …Poxel annonce la tenue d’une Assemblée Générale Mixte le 11 février 2025 à... |
Poxel: Ordinary and Extraordinary General Meeting to Be Held on Febru…Poxel announces that a Combined General Meeting will be held on February... |
Poxel annonce la délivrance d’un brevet en Chine protégeant l’utilisa…Durée de vie des brevets couvrant l’Imeglimine en Chine étendue jusqu’en... |
Poxel Announces the Grant of Patent in China Protecting the Use of Im…Patent life covering Imeglimin in China extended to 2039 Ongoing... |
Poxel to receive sales-based payment and higher level of royalties fr…Poxel eligible for royalties equaling 10% of all TWYMEEG® net sales for... |
Poxel annonce l’atteinte des 5 milliards de yens de ventes nettes de …Poxel éligible à des redevances égales à 10% de la totalité des ventes... |
0.21 | 3 | EC | 10:35:22 |
0.21 | 2 | EC | 10:35:22 |
0.21 | 2,997 | EC | 10:29:03 |
0.215 | 477 | EC | 10:27:56 |
0.21 | 1,000 | EC | 10:24:39 |
0.2115 | 1,453 | EC | 10:20:22 |
0.215 | 284 | EC | 09:35:54 |
0.215 | 152 | EC | 09:35:54 |
0.215 | 284 | EC | 09:35:54 |
0.215 | 95 | EC | 09:35:53 |
0.215 | 495 | EC | 09:35:53 |
0.215 | 1,250 | EC | 09:30:26 |
0.215 | 1,482 | EC | 09:29:10 |
0.2145 | 750 | EC | 09:29:10 |
0.2145 | 752 | EC | 09:29:10 |
0.214 | 1,016 | EC | 09:29:10 |
0.214 | 436 | EC | 09:28:36 |
0.214 | 1,340 | EC | 09:28:34 |
0.214 | 4,660 | EC | 09:28:34 |
0.2135 | 100 | EC | 09:23:45 |
0.21 | 4,760 | EC | 09:22:03 |
0.212 | 240 | EC | 09:16:28 |
0.2145 | 1,248 | EC | 08:18:09 |
0.214 | 700 | EC | 08:18:09 |
0.2135 | 700 | EC | 08:18:09 |
0.213 | 2,220 | EC | 08:18:09 |
0.2125 | 700 | EC | 08:18:09 |
0.212 | 2,201 | EC | 08:18:09 |
0.2115 | 6,731 | EC | 08:18:09 |
0.2115 | 1,600 | EC | 08:07:35 |
0.2115 | 6,000 | EC | 08:07:35 |
0.2115 | 499 | EC | 07:44:15 |
0.2115 | 1,241 | EC | 07:42:33 |
0.2115 | 3,759 | EC | 07:42:33 |
0.2115 | 1,000 | EC | 07:36:12 |
0.207 | 10 | EC | 07:28:35 |
0.207 | 10 | EC | 07:28:35 |
0.212 | 1,031 | EC | 07:27:38 |
0.212 | 6,952 | EC | 07:27:38 |
0.212 | 700 | EC | 07:27:38 |
0.212 | 11,817 | EC | 07:27:38 |
0.211 | 200 | EC | 06:59:22 |
0.2055 | 500 | EC | 06:51:32 |
0.2055 | 900 | EC | 06:40:57 |
0.211 | 10 | EC | 06:37:31 |
0.2055 | 16,435 | EC | 06:34:48 |
0.206 | 8,535 | EC | 06:34:48 |
0.206 | 1,000 | EC | 06:34:48 |
0.206 | 1,000 | EC | 06:34:48 |
0.2065 | 3,800 | EC | 06:34:48 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions